Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased nitrate intake from beetroot juice over 4 weeks affects nitrate metabolism, but not vascular function or blood pressure in older adults with hypertension.
Fejes R, Lutnik M, Weisshaar S, Pilat N, Wagner KH, Stüger HP, Peake JM, Woodman RJ, Croft KD, Bondonno CP, Hodgson JM, Wolzt M, Neubauer O. Fejes R, et al. Among authors: hodgson jm. Food Funct. 2024 Apr 22;15(8):4065-4078. doi: 10.1039/d3fo03749e. Food Funct. 2024. PMID: 38546454 Free PMC article. Clinical Trial.
Source-specific nitrate and nitrite intakes and associations with sociodemographic factors in the Danish Diet Cancer and Health cohort.
Erichsen DW, Pokharel P, Kyrø C, Schullehner J, Zhong L, Bondonno CP, Dalgaard F, Fjeldstad Hendriksen P, Sigsgaard T, Hodgson JM, Olsen A, Tjønneland A, Bondonno NP. Erichsen DW, et al. Among authors: hodgson jm. Front Nutr. 2024 Feb 27;11:1326991. doi: 10.3389/fnut.2024.1326991. eCollection 2024. Front Nutr. 2024. PMID: 38476601 Free PMC article.
2023 - biotech back in the mainstream.
Hodgson J. Hodgson J. Nat Biotechnol. 2024 Feb;42(2):170-172. doi: 10.1038/s41587-024-02126-1. Nat Biotechnol. 2024. PMID: 38361065 No abstract available.
Drug pipeline 4Q23 - gene editing delivers.
Hodgson J. Hodgson J. Nat Biotechnol. 2024 Feb;42(2):167-169. doi: 10.1038/s41587-024-02125-2. Nat Biotechnol. 2024. PMID: 38361057 No abstract available.
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Fenwick N, Weston R, Wheatley K, Hodgson J, Marshall L, Elliott M, Makin G, Ng A, Brennan B, Lowis S, Adamski J, Kilday JP, Cox R, Gattens M, Moore A, Trahair T, Ronghe M, Campbell M, Campbell H, Williams MW, Kirby M, Van Eijkelenburg N, Keely J, Scarpa U, Stavrou V, Fultang L, Booth S, Cheng P, De Santo C, Mussai F. Fenwick N, et al. Among authors: hodgson j. Front Oncol. 2024 Jan 31;14:1296576. doi: 10.3389/fonc.2024.1296576. eCollection 2024. Front Oncol. 2024. PMID: 38357205 Free PMC article.
1,330 results